Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05661838
What this trial is testing

Effect of Intraoperative Allogeneic Blood Transfusion on Postoperative Pulmonary Complications

Who this might be right for
Spinal FusionTransfusionPulmonary Complication
Second Affiliated Hospital, Zhejiang University, School of Medicine 272
Early research (Phase 1)Study completedNCT03371485
What this trial is testing

AST-VAC2 Vaccine in Patients With Non-small Cell Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung Cancer
Cancer Research UK 9
Testing effectiveness (Phase 2)Ended earlyNCT04269850
What this trial is testing

Fecal Microbiota Transplantation With Ruxolitinib and Steroids as an Upfront Treatment of Severe Acute Intestinal GVHD

Who this might be right for
Intestinal GVHD
St. Petersburg State Pavlov Medical University 2
Early research (Phase 1)Ended earlyNCT05298358
What this trial is testing

RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis

Who this might be right for
Systemic Sclerosis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1
Early research (Phase 1)Study completedNCT01884155
What this trial is testing

Allogeneic Umbilical Cord Blood Therapy for Stroke

Who this might be right for
Stroke
MinYoung Kim, M.D. 5
Not applicableNot Yet RecruitingNCT07762508
What this trial is testing

VABu Conditioning Regimen in Allo-HSCT for AML Patients

Who this might be right for
Leukemia, Myeloid, Acute(AML)Hematopoietic Stem Cell Transplantation (HSCT)
The First Affiliated Hospital of Soochow University 42
Not applicableStudy completedNCT02628210
What this trial is testing

Interbody Spacers With map3® Cellular Allogeneic Bone Graft in Anterior or Lateral Lumbar Interbody Fusion

Who this might be right for
SpondylosisSpondylolisthesisDegenerative Disc Disease
RTI Surgical 30
Early research (Phase 1)Ended earlyNCT00684255
What this trial is testing

Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)

Who this might be right for
Systemic Lupus ErythematosusSystemic Sclerosis
New York Medical College 1
Testing effectiveness (Phase 2)Ended earlyNCT02418325
What this trial is testing

Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Genesis Limited 69
Early research (Phase 1)UnknownNCT02580617
What this trial is testing

Evaluate the Safety of ALLO-ASC-CD for Treatment of Crohn's Disease

Who this might be right for
Crohn's Disease
Anterogen Co., Ltd. 9
Testing effectiveness (Phase 2)Active Not RecruitingNCT02861417
What this trial is testing

Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmHigh Risk Acute Myeloid LeukemiaHigh Risk Myelodysplastic Syndrome+11 more
M.D. Anderson Cancer Center 204
Testing effectiveness (Phase 2)Study completedNCT03149055
What this trial is testing

Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT)

Who this might be right for
Hematologic MalignancyMyeloproliferative Disorder
Memorial Sloan Kettering Cancer Center 99
Testing effectiveness (Phase 2)Study completedNCT03820908
What this trial is testing

Bisantrene for Relapsed /Refractory AML

Who this might be right for
Acute Myelogenous LeukemiaAllogeneic Stem Cell Transplantation
Sheba Medical Center 10
Early research (Phase 1)WithdrawnNCT04655391
What this trial is testing

Glasdegib-Based Treatment Combinations for the Treatment of Patients With Relapsed Acute Myeloid Leukemia Who Have Undergone Hematopoietic Cell Transplantation

Who this might be right for
Recurrent Acute Myeloid Leukemia
City of Hope Medical Center
Large-scale testing (Phase 3)Study completedNCT00606723
What this trial is testing

Allogenic Stem Cell Transplantation for Children, Adolescents and Young Adults With Relapsed or Refractory AML

Who this might be right for
Acute Myeloid Leukemia (AML)
Hannover Medical School 154
Not applicableLooking for participantsNCT06715046
What this trial is testing

Cell Free DNA Profiling As a Tool to Monitor Clinically-Relevant Events in Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
GVHD - Graft-Versus-Host DiseaseInfections After HSCTTransplant Associated Microangiopathy TAM+2 more
University of Turin, Italy 30
Testing effectiveness (Phase 2)Study completedNCT05120570
What this trial is testing

PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation

Who this might be right for
Acute LeukemiaMyelodysplastic SyndromesMyeloproliferative Neoplasm+1 more
Masonic Cancer Center, University of Minnesota 16
Early research (Phase 1)UnknownNCT01902082
What this trial is testing

Adipose-derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome

Who this might be right for
ARDS
Shaoxing Second Hospital 20
Not applicableUnknownNCT01060176
What this trial is testing

Three Dose Regimen of Tranexamic Acid in Cardiac Surgery

Who this might be right for
Hemostasis
Chinese Academy of Medical Sciences, Fuwai Hospital 600
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07347197
What this trial is testing

Endocardial Delivery for Myocardial Regeneration Using Allogeneic iPSC-derived Cardiomyocyte Spheroids for HF With Systolic Dysfunction (EMERALD Study)

Who this might be right for
Heart FailureIschemic Heart FailureIschemic Heart Disease+1 more
Heartseed Inc. 14
Next Page